just health 21

T cells from a HIV-infected affected person have been stained for HIV RNA (crimson), HIV protein (inexperienced) and the nucleus (blue) and analyzed by microscopy. This strategy permits researchers to investigate very uncommon HIV-infected cells from people in unprecedented element. Credit score: Dr. Daniel Kaufmann laboratory, CRCHUM. Discovery of a novel, superior approach to establish the uncommon cells the place human immunodeficiency virus (HIV) hides in sufferers taking antiretroviral remedy (ART). This is a crucial step ahead within the seek for a HIV/AIDS remedy. Why get up the virus? To higher kill it, in fact. A workforce from the College of Montreal Hospital Analysis Centre (CRCHUM) has taken an essential step ahead within the seek for a HIV/AIDS remedy. The laboratory of Dr. Daniel Kaufmann has developed a extremely correct approach for detecting the uncommon cells that conceal the virus and stop present ...

During pregnancy, infections with Plasmodium malaria parasites can be asymptomatic but still lead to maternal anemia, low birthweight, and fetal loss.. In areas where malaria is endemic, the World Health Organization currently recommends treating women with SP three or four times during pregnancy. But in some areas, more than 90 percent of Plasmodium parasites are now resistant to SP. In the new study, the researchers compared this standard of care to a screening approach where women are tested approximately monthly for malaria using rapid diagnostic tests and treated with a different drug, dihydroartemisinin-piperaquine (DP) only if positive for the parasite. The study involved 1873 HIV-negative women at three sites in Malawi who were randomly assigned to receive either strategy. The prevalence of adverse birth outcomes and maternal deaths was similar in the two groups. However, there were eight percent more cases of malaria at delivery in women assigned to the rapid screening...

Reliable biomarkers such as that identified by the researchers offer insight into how HIV-associated cognitive impairment develops but also promises improved diagnostic testing and improved treatment decisions. The findings are published in the scientific journal  Nature Scientific Reports  (September 2016) by UH Mānoa scientists Lishomwa Ndhlovu, MD, PhD, and Alika Maunakea, PhD, at the John A. Burns School of Medicine (JABSOM) and collaborators at UHM and the University of California San Francisco. "These results offer the first significant window into the mechanisms driving HIV-related brain damage and how to track the disease," said Dr. Ndhlovu, Associate Professor in JABSOM's Department of Tropical Medicine. Combination antiretroviral therapies have improved HIV survival. If started early and taken daily for life, antiretroviral therapies can result in fewer non-AIDS related complications. However, HIV still impacts the brain. Around 40% of individuals even...

We know from HIV research that around one percent of people infected with HIV form antibodies that combat different virus strains. These broadly neutralizing HIV antibodies (bnAbs) bind to structures on the surface of the virus which barely change and are identical in different viral strains. Dubbed "spikes," these sugar and protein complexes are the only surface structures that stem from the HIV virus itself and can be attacked by the immune system via antibodies. Due to their broad impact, these antibodies constitute a promising cornerstone for the development of an effective vaccine against HIV. Virus load, virus diversity and duration of infection encourage antibody formation A Switzerland-wide team of researchers headed by the University of Zurich and University Hospital Zurich conducted an extensive study on the factors responsible for the formation of broadly neutralizing antibodies against HIV. They examined around 4,500 people infected with HIV who are record...

A partnership sparked by the National Institute for Health Research (NIHR) is behind this collaborative UK effort for the new treatment, which is a first-of-its-kind. Six years ago this month, a meeting took place between five leading UK research establishments which resulted in a shared commitment to find a cure for HIV. A partnership sparked by the National Office for Clinical Research Infrastructure (NOCRI), part of the NIHR, identified in that meeting that while there is research into treatment of HIV, as there is for many chronic conditions, there was no research into eradication of the disease. Each of the British research institutions present -- Oxford University, University of Cambridge, Imperial College London, King's College London and University College London -- agreed that they could provide a part of the jigsaw needed to find the cure, but could not achieve this in isolation. Managing Director of NOCRI Mark Samuels said: "This was a meeting of some of ...

Researchers at McMaster College and two American universities have taken one other step nearer to creating a way more efficient, "one-punch" common flu vaccine. Their newest findings, printed on-line within the journal  Proceedings of the Nationwide Academy of Science USA (PNAS) , construct upon their earlier discovery of a category of antibodies able to neutralizing essentially the most harmful kinds of Influenza viruses . These antibodies, in response to the researchers, basically "prepare" the immune system to acknowledge a portion of the virus that doesn't change from year-to-year and, in doing so, can pave the way in which towards a common vaccine that must be given simply as soon as and will shield towards all future strains of the flu, together with mutated strains. Seasonal flu vaccines work by producing antibodies that bind to the virus and stop it from infecting cells. Common flu vaccines do that ...

Children who're HIV-positive nonetheless keep free of AIDS are very unusual. Inside the absence of antiretroviral treatment, over 99% of individuals contaminated with HIV go on to develop full-blown AIDS, and the state of affairs evolves further shortly in children than in adults. Nonetheless, between 5 and 10% of perinatally contaminated HIV-positive children avoid this future. Credit score rating: © Krasimira Nevenova / Fotolia Some HIV-infected -- and untreated -- children do not develop AIDS. A model new study displays that they administration the virus one other manner from the few contaminated adults who keep disease-free, and sheds delicate on the reasons for this distinction. Children who're HIV-positive nonetheless keep free of AIDS are very unusual. Inside the absence of antiretroviral treatment, over 99% of individuals contaminated with HIV go on to develop full-blown AIDS, and the state of affairs evo...

Older individuals differ from younger patients with HIV in many ways-for example, they tend to have an increased risk for late or missed diagnoses, differing side effects from antiretroviral therapies, and increased comorbidities. Only a few existing treatment guidelines make distinctions when it comes to care by age, however. By examining findings from clinical research, investigators have now offered easy-to-follow approaches for providing care to older people living with HIV. "Our article recommends an overall strategy in which various tools are used to provide information on the likely course of HIV for an individual, which clinicians can then use to guide discussions on personalized, person-centered care," said Dr. Jonathan Appelbaum, co-author of the  Journal of the American Geriatrics Society  article. One tool that may be especially useful is the Veterans Aging Cohort Stud y (VACS) Index, which can help distinguish between those who are aging well and those who m...

The study identifies the mechanism on how the cell's innate immune system (known as the interferon response) responds to HIV infection and how the virus affects this interferon response. The viral protein Vpr triggers the interferon response in T cells (as also in dendritic cells, other cells of the immune system which are also infected by HIV). Vpu, another viral protein, suppresses the interferon response. This discovery is the result of research by Dr. Jolien Vermeire and colleagues under supervision of Dr. Bruno Verhasselt at Ghent University and Ghent University Hospital A better understanding of the innate defense against H IV could in the long term allow to complement the current treatment. Because HIV infects and functionally impairs immune cells, untreated patients loose a functional immune system. As a consequence, germs and some cancers are given free rein (AIDS). Even if the virus is kept under control with medication, inflammation and degradation of establishe...

Studies have shown that PrEP, a once-daily pill, reduces HIV incidenc e by 92 percent in HIV-negative people who are at high risk for HIV, including men who have unprotected sex with men, and it is recommended for that group by the Centers for Disease Control and Prevention. In 2011, HIV incidence among gay and bisexual men nationally was 18 percent; in Baltimore, it is estimated to be 31 percent. Still, since the U.S. Food and Drug Administration approved PrEP in 2012, only five percent of high-risk individuals have taken it for HIV prevention. The new findings, published online in the  American Journal of Preventive Medicine , suggest that many health care providers don't even discuss PrEP, even with high-risk patients they know are gay or bisexual or have been tested for other sexually transmitted diseases. The Centers for Disease Control and Prevention says that as many as one-third of physician s may not even know PrEP is an option. "Doctors have limited time with ...